TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Orion Pharma AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
87,085
|
82,647
|
74,776 |
| Financial expenses |
3
|
1
|
0 |
| Earnings before taxes |
3,963
|
3,578
|
3,149 |
| EBITDA |
3,736
|
3,433
|
3,116 |
| Total assets |
22,142
|
19,369
|
25,366 |
| Current assets |
21,859
|
19,069
|
25,047 |
| Current liabilities |
7,060
|
3,632
|
11,090 |
| Equity capital |
14,789
|
15,458
|
14,006 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
51
|
49
|
48 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
66.8%
|
79.8%
|
55.2% |
| Turnover per employee |
1,708
|
1,687
|
1,558 |
| Profit as a percentage of turnover |
4.6%
|
4.3%
|
4.2% |
| Return on assets (ROA) |
17.9%
|
18.5%
|
12.4% |
| Current ratio |
309.6%
|
525.0%
|
225.9% |
| Return on equity (ROE) |
26.8%
|
23.1%
|
22.5% |
| Change turnover |
7,248
|
7,653
|
2,134 |
| Change turnover % |
9%
|
10%
|
3% |
| Chg. No. of employees |
2
|
1
|
0 |
| Chg. No. of employees % |
4%
|
2%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.